PharVision Advisers’s Adobe ADBE Stock Holding History

PharVision Advisers’s Portfolio ADBE Stock Details ADBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-622	Closed	-$219K	–	673
2025 Q3	$219K	Sell	622 -60	-9%	-$21.5K	0.12%	432
2025 Q2	$264K	Buy	+682	New	+$263K	0.38%	114

Other funds holding ADBE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

PharVision Advisers's ADBE Position: Q4 2025 in Review

PharVision Advisers sold out of Adobe (ADBE) in Q4 2025, closing a stake of 622 shares — an estimated $219K sold.

PharVision Advisers first reported a position in ADBE in Q2 2025 and held it in 2 quarters. The position peaked at $264K in Q2 2025. 2,527 funds tracked by Wall St. Rank hold ADBE as of Q4 2025.

PharVision Advisers reported no remaining Adobe position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 622 Adobe shares in Q4 2025, an estimated $219K.
PharVision Advisers first reported a position in Adobe in Q2 2025 and held it in 2 quarters.
PharVision Advisers's Adobe position peaked at $264K in Q2 2025.
2,527 funds tracked by Wall St. Rank held Adobe as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.